Clinical Trial Update: A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating vapendavir in asthmatic adults with symptomatic human rhinovirus infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Vapendavir (vapendavir)

Snippet

Sponsor: Biota Pharmaceuticals, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED